<P>A randomized controlled trial has started in both Japan and Korea to evaluate the role of gastrectomy in the management of incurable advanced gastric cancer (AGC). Patients with AGC diagnosed as having a single non-curable factor are randomiz...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A107640308
Fujitani, K. ; Yang, H.-K. ; Kurokawa, Y. ; Park, D. J. ; Tsujinaka, T. ; Park, B.-J. ; Fukuda, H. ; Noh, S. H. ; Boku, N. ; Bang, Y.-J. ; Sasako, M. ; Lee, J.-I.
2008
-
SCIE,SCOPUS
학술저널
504-506(3쪽)
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
<P>A randomized controlled trial has started in both Japan and Korea to evaluate the role of gastrectomy in the management of incurable advanced gastric cancer (AGC). Patients with AGC diagnosed as having a single non-curable factor are randomiz...
<P>A randomized controlled trial has started in both Japan and Korea to evaluate the role of gastrectomy in the management of incurable advanced gastric cancer (AGC). Patients with AGC diagnosed as having a single non-curable factor are randomized to gastrectomy plus chemotherapy or chemotherapy alone. Surgeons at 33 specialized centers in Japan and at 15 high-volume hospitals in Korea will recruit 330 patients. Primary end-point is overall survival, and secondary end-points are progression-free survival and adverse events associated with either gastrectomy or chemotherapy.</P>